New Weight-Loss Drug Enters South African Market
Aspen, a South African pharmaceutical company, has received regulatory approval to market Mounjaro for chronic weight management.
The approval from the South African Health Products Regulatory Authority (SAHPRA) allows the once-weekly injection to be available to patients starting October.
The medication, known as tirzepatide, will be marketed as an adjunct to a reduced-calorie diet and increased physical activity.
providing a new tool for addressing what has become a global health challenge
This development expands treatment options for weight management in South Africa, where obesity affects a growing portion of the population.
Author's summary: Aspen secures approval for Mounjaro weight-loss drug.